• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Actually, after all these decades of PAP rule, what is one globally recognised Singaporean product or service?

All I can think about is money laundering service
No lah, we have a world class “Cheap” public housing aka Hardland Pigeon Hole mah

Sone famous big shot sirs give a beautiful presentation in a world class forum and won many praises from AMDK around 200-300moons ago
 
Yes there is one product recognised globally.

PGI - Paul glaucoma implant. And one of my colleague went for it.


A new glaucoma implant developed by a National University Health System team reduces patients’ eye pressure (also known as intraocular pressure, IOP) for a longer period of time and enables less reliance on eye drops. The Paul Glaucoma Implant (PGI) is a glaucoma drainage device which regulates IOP and prevents further progression of the disease that leads to blindness. With a higher efficacy and safety profile in reducing IOP, this medical technology innovation advances the treatment of glaucoma. In patients with medically uncontrolled glaucoma, the PGI offers a viable option in the management of refractory glaucoma, a severe form of glaucoma that has a high risk of failure from conventional trabeculectomy surgery.


Led by Professor Paul Chew from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Senior Consultant at the Department of Ophthalmology, National University Hospital (NUH), the research team involved in the development and design of the implant comprises Adjunct Associate Professor Chelvin Sng, NUS Medicine, Visiting Consultant from the Department of Ophthalmology, NUH, and Medical Director, Chelvin Sng Eye Centre, as well as researchers at the National University of Singapore.
 
Taiwan's TSMC took approximately 50 years to become the world's leading semiconductor chip manufacturer. The Kuomintang (KMT) government foresaw the potential of the industry and sent local students to the US for study, with the goal of gaining experience in the field. Many of these individuals later returned to Taiwan to establish their own chip manufacturing facilities.
 
Back
Top